Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Other options include SGLT2 inhibitors such as dapagliflozin or empagliflozin, DPP-4 inhibitors like sitagliptin, or traditional agents such as metformin (if not already prescribed), sulfonylureas, or insulin therapy
A market prediction in September 2001 suggested a 12% probability of NS-2330 reaching the market for PD and a 15% probability for AD
Ayuda a mantener masa muscular
High blood sugar levels damage blood vessels in the retina, potentially causing vision problems and blindness if untreated
US$ 22.94
US$ 25.62
US$ 23.83
US$ 23.81
US$ 28.55
US$ 29.12
